Author

Sun Jin Kim

Institution: Kolon Life Science (South Korea)

Observed institution: Kolon Life Science (South Korea)

ORCID: 0009-0005-2411-9369

Observed ORCID: 0009-0005-2411-9369

OpenAlex ID: A5136256567

Safety and tolerability of KLS-2031 in lumbosacral radiculopathy–induced neuropathic pain: randomized, placebo-controlled phase 1/2a trial

2026 · Todd Bertoch, Haeun Park, et al. · PAIN Reports

Abstract 4367: Strong therapeutic efficacy of oncolytic virus KLS-3021 in orthotopic head and neck cancer models regardless of PD-L1 expression via tumor microenvironment remodeling

2026 · Sungmin Lee, Jinwon Seo, et al. · Cancer Research

KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma

2026 · Kiwon Park, Jinwon Seo, et al. · Molecular Therapy Oncology

KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer

2026 · Jinwon Seo, Kiwon Park, et al. · Frontiers in Oncology

Works count: 4

Citation count:

H-index:

I10-index: